We are live on ! Find out more
PCM

Palisade Capital Management Portfolio holdings

AUM $3B
1-Year Est. Return 14%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+14%
3 Year Est. Return
+46.63%
5 Year Est. Return
+57.43%
10 Year Est. Return
+264.35%
AUM
$3.98B
AUM Growth
-$150M
Cap. Flow
-$805M
Cap. Flow %
-20.2%
Top 10 Hldgs %
10.16%
Holding
526
New
53
Increased
131
Reduced
153
Closed
33

Sector Composition

Rank Sector Weight
1 Technology 15.24%
2 Industrials 12.54%
3 Healthcare 10.66%
4 Consumer Discretionary 9.82%
5 Financials 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMSGP
226
DELISTED
Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1
AMSGP
$4.25M 0.11%
+34,200
New +$4.08M
CODI icon
227
Compass Diversified
CODI
$831M
$4.22M 0.11%
246,790
-3,095
-1% -$51.5K
CHRD icon
228
Chord Energy
CHRD
$7.49B
$4.1M 0.1%
288,107
-48,809
-14% -$717K
AA icon
229
Alcoa
AA
$13.2B
$4.09M 0.1%
131,695
+34,514
+36% +$1.24M
SJT
230
San Juan Basin Royalty Trust
SJT
$119M
$4.01M 0.1%
335,447
+55,650
+20% +$770K
PPLI
231
People Inc
PPLI
$3.18B
$4M 0.1%
331,528
+36,650
+12% +$424K
HON icon
232
Honeywell
HON
$77.8B
$3.93M 0.1%
41,917
+2,231
+6% +$204K
BRK.B icon
233
Berkshire Hathaway Class B
BRK.B
$1.12T
$3.85M 0.1%
26,683
+960
+4% +$141K
TWX
234
DELISTED
Time Warner Inc
TWX
$3.73M 0.09%
44,200
+4,580
+12% +$381K
KDP icon
235
Keurig Dr Pepper
KDP
$40.9B
$3.67M 0.09%
46,761
-100
-0.2% -$7.73K
EPR.PRE icon
236
EPR Properties 9.00% Series E Preferred Shares
EPR.PRE
$112M
$3.67M 0.09%
109,400
-500
-0.5% -$16.8K
SAGE
237
DELISTED
Sage Therapeutics
SAGE
$3.66M 0.09%
+72,797
New +$3.13M
GHL
238
DELISTED
Greenhill & Co., Inc.
GHL
$3.58M 0.09%
90,311
+247
+0.3% +$9.66K
LNKD
239
DELISTED
LinkedIn Corporation
LNKD
$3.57M 0.09%
14,276
-12,707
-47% -$3.16M
RARE icon
240
Ultragenyx Pharmaceutical
RARE
$2.51B
$3.41M 0.09%
+54,981
New +$3.05M
NAVI icon
241
Navient
NAVI
$839M
$3.36M 0.08%
165,100
+1,100
+0.7% +$22.6K
SWH
242
DELISTED
Stanley Black & Decker, Inc.
SWH
$3.31M 0.08%
29,166
BRK.A icon
243
Berkshire Hathaway Class A
BRK.A
$1.12T
$3.26M 0.08%
15
-4
-21% -$884K
GMLP
244
DELISTED
Golar LNG Partners LP
GMLP
$3.14M 0.08%
+116,844
New +$3.14M
ADTN icon
245
Adtran
ADTN
$617M
$3.07M 0.08%
164,668
-119,139
-42% -$2.53M
ARCC icon
246
Ares Capital
ARCC
$14.3B
$3.04M 0.08%
177,300
+5,500
+3% +$91.8K
RHT
247
DELISTED
Red Hat Inc
RHT
$3.02M 0.08%
+39,900
New +$2.7M
ACTG icon
248
Acacia Research
ACTG
$461M
$2.95M 0.07%
275,341
-574,887
-68% -$7.5M
MCD icon
249
McDonald's
MCD
$195B
$2.86M 0.07%
29,371
-650
-2% -$61.7K
HIG icon
250
Hartford Financial Services
HIG
$39.3B
$2.59M 0.07%
61,900
+19,793
+47% +$811K

Similar funds

Palisade Capital Management's Q1 2015 Portfolio in Review

As of Q1 2015, Palisade Capital Management held 526 positions worth $3.98B, down 3.6% from $4.13B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Palisade Capital Management withdrew a net $805M in Q1 2015, closing 33 positions and reducing 153 holdings. Its most notable exit was CUBIST PHARMACEUTICALS INC, an estimated $22.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Palisade Capital Management opened a new position in ACTAVIS PLC Pfd Conv Ser A (Irl) worth $20.8M.

  • Palisade Capital Management's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 20,225 shares worth $20.8M.
  • Palisade Capital Management added most to Avient in Q1 2015, an estimated $10M increase.
  • Palisade Capital Management's biggest Q1 2015 reduction was Proofpoint, Inc., cutting an estimated $23.8M.
  • Palisade Capital Management fully exited CUBIST PHARMACEUTICALS INC in Q1 2015, selling an estimated $22.4M.
  • Palisade Capital Management's ten largest holdings make up 10% of its $3.98B portfolio in Q1 2015.
  • Palisade Capital Management opened 53 new positions and closed 33 in Q1 2015.
  • Palisade Capital Management's portfolio value fell 3.6% quarter-over-quarter to $3.98B.

Based on Palisade Capital Management's 13F filing for Q1 2015, filed 13 May 2015.